Allison Dyson

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

B. Douglas Smith, Gail J. Roboz, Roland B. Walter et al. · Blood · 2014 · 61 citations

Medicine, Hematology, Oncology +16

Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine

Steve Rockman, Dorit Becher, Allison Dyson et al. · Vaccine · 2014 · 29 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere Trivalent Influenza Vaccine is associated with adverse events

Steve Rockman, Allison Dyson, Sandra Koernig et al. · Vaccine · 2014 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine

Eugene Maraskovsky, Steve Rockman, Allison Dyson et al. · Vaccine · 2012 · 23 citations

Medicine, Immunology, Pediatrics +17

CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa

Cristina Gamell, Aleksandra Bankovacki, Karen Scalzo‐Inguanti et al. · British Journal of Dermatology · 2023 · 16 citations · Full text

Life Sciences, Dermatology, Immunology +17